These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6917563)

  • 1. Immunoelectrophoretic studies of prekallikrein in human plasma.
    Hathaway WE; Christian J; McGregor R; Borden C
    Thromb Res; 1982 Feb; 25(3):267-75. PubMed ID: 6917563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
    Donaldson VH; Kleniewski J; Saito H; Sayed JK
    J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Fletcher factor (plasma prekallikrein) deficiency with partial deficiency of Hageman factor (factor XII): report of a case with observation on in vivo and in vitro leukocyte chemotaxis.
    Poon MC; Moore MR; Castleberry RP; Lurie A; Huang ST; Lehmeyer J
    Am J Hematol; 1982 May; 12(3):261-70. PubMed ID: 6919394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen.
    Bouma BN; Vlooswijk RA; Griffin JH
    Blood; 1983 Nov; 62(5):1123-31. PubMed ID: 6626744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological studies of human Factor XI and prekallikrein: demonstration of complex formation with high molecular weight kininogen.
    Bouma BN; Vlooswijk RA; Griffin JH
    Adv Exp Med Biol; 1983; 156():109-13. PubMed ID: 6552836
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
    Scott CF; Colman RW
    J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of contact factors in sickle cell disease.
    Gordon EM; Klein BL; Berman BW; Strandjord SE; Simon JE; Coccia PF
    J Pediatr; 1985 Mar; 106(3):427-30. PubMed ID: 3844465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation.
    Bouma BN; Kerbiriou DM; Vlooswijk RA; Griffin JH
    J Lab Clin Med; 1980 Oct; 96(4):693-709. PubMed ID: 6903191
    [No Abstract]   [Full Text] [Related]  

  • 17. Prekallikrein deficiency in man.
    Wuepper KD
    J Exp Med; 1973 Dec; 138(6):1345-55. PubMed ID: 4762550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.
    Saito H; Poon MC; Vicic W; Goldsmith GH; Menitove JE
    J Lab Clin Med; 1978 Jul; 92(1):84-95. PubMed ID: 659966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.